Proceedings of the 2019 Canadian Inflammatory Myopathy Study Symposium: Clinical Trial Readiness in Myositis

Affiliations

• ¹ V. Leclair, MD, Department of Medicine, McGill University, and Division of Rheumatology, Jewish General Hospital, Montreal, Quebec, Canada; [email protected].
• ² O. Landon-Cardinal, MD, Department of Medicine, Université de Montréal, and Division of Rheumatology and Research Center, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
• ³ R. Aggarwal, MD, MSc, Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
• ⁴ N. Bansback, PhD, University of British Columbia and Arthritis Research Canada, Vancouver, British Columbia, Canada.
• ⁵ C. Campbell, MD, Department of Pediatrics, London Children's Hospital, University of Western Ontario, London, Ontario, Canada.
• ⁶ B.M. Feldman, MD, MSc, Faculty of Medicine and IHPME Dalla Lana School of Public Health, University of Toronto, and Division of Rheumatology, The Hospital for Sick Children, Toronto, Ontario, Canada.
• ⁷ M. Jarry, Patient Advocate, S. McNamara, PhD, B. White, MD, Corbus Pharmaceutical Holdings Inc., Norwood, Massachusetts, USA.